The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index; none of the 20 sources its claims cite is checked for support yet.
Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes
Abstract
Context: Low testosterone levels are common in men with type 2 diabetes and may be associated with insulin resistance. Objective: We investigated prevalence of testosterone deficiency and the relationship between testosterone and insulin resistance in a large cohort of men with type 2 and type 1 diabetes. Design: The study was a cross-sectional survey of 580 men with type 2 diabetes and 69 men with type 1 diabetes. A subgroup of 262 men with type 2 diabetes was then reassessed after a median of 6 months. Results: Forty-three percent of men with type 2 diabetes had a reduced total testosterone, and 57% had a reduced calculated free testosterone. Only 7% of men with type 1 diabetes had low total testosterone. By contrast, 20.3% of men with type 1 diabetes had low calculated free testosterone, similar to that observed in type 2 diabetes (age-body mass index adjusted odds ratio = 1.4; 95% confidence interval = 0.7–2.9). Low testosterone levels were independently associated with insulin resistance in men with type 1 diabetes as well as type 2 diabetes. Serial measurements also revealed an inverse relationship between changes in testosterone levels and insulin resistance. Conclusions: Testosterone deficiency is common in men with diabetes, regardless of the type. Testosterone levels are partly influenced by insulin resistance, which may represent an important avenue for intervention, whereas the utility of testosterone replacement remains to be established in prospective trials.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
In a single-center cross-sectional survey, testosterone deficiency was common in men with diabetes: 43% of men with type 2 diabetes had low total testosterone and 57% had low calculated free testosterone, while 20.3% of men with type 1 diabetes had low calculated free testosterone. Low testosterone indices were independently associated with insulin resistance in both diabetes types, and longitudinal changes in testosterone were inversely related to changes in insulin resistance in a type 2 diabetes subgroup.
Key findings
- Among men with type 2 diabetes, 43% had low total testosterone (<10 nmol/L) and 57% had low calculated free testosterone (<0.23 nmol/L); among men with type 1 diabetes, 7% had low total testosterone but 20.3% had low calculated free testosterone, similar to age- and BMI-adjusted men with type 2 diabetes (adjusted odds ratio 1.4; 95% CI 0.7–2.9).
- Low total testosterone in type 2 diabetes was independently associated with insulin resistance by HOMA-IR (odds ratio 1.2; 95% CI 1.0–1.4), and calculated free testosterone was independently associated with insulin sensitivity in type 2 diabetes (partial correlation coefficient −0.10; P = 0.02) and with eGDR in type 1 diabetes (P = 0.04).
- In 262 men with type 2 diabetes reassessed after a median of 6 months, the change in total testosterone was inversely related to the change in HOMA-IR (P = 0.01), and the change in calculated free testosterone was inversely correlated with the change in HOMA-IR (P = 0.03).
- The prevalence of low calculated free testosterone approximately doubled per decade of age in type 2 diabetes (adjusted odds ratio 2.0; 95% CI 1.4–2.4) and in type 1 diabetes (adjusted odds ratio 2.4; 95% CI 1.4–3.9).
Methods
- Cross-sectional survey of 580 men with type 2 diabetes and 69 men with type 1 diabetes at a single clinic; 6 men with type 2 diabetes were excluded from statistical analysis, and a randomly selected subgroup of 262 men with type 2 diabetes was reassessed after a median of 6 months (range 1–15 months).
- Fasting blood samples were drawn between 0800 and 1000 h; total testosterone was measured by Access assay, SHBG by Immulite, and calculated free testosterone was derived using Vermeulen’s formula. Low total testosterone was defined as <10 nmol/L and low calculated free testosterone as <0.23 nmol/L.
- Insulin resistance was estimated by HOMA-IR in type 2 diabetes and by eGDR in type 1 diabetes; analyses used logistic regression, multiple regression, ANOVA, analysis of covariance, and nonparametric tests as appropriate.
Limitations
- The paper states that it did not obtain a detailed symptomatology history, so the biochemical testosterone deficiency may not represent a true hypogonadal state; it also states that a single low testosterone level is inadequate for diagnosing hypogonadism because of variability, and on repeat testing 27% of men with low total testosterone and 33% with low calculated free testosterone had normal levels.
- The paper states that longitudinal changes in testosterone in type 1 diabetes remain to be explored and that the utility of testosterone replacement remains to be established in prospective trials.
- Evident from the text: the study was observational and single-center, with a tertiary referral cohort that had longstanding diabetes and high complication prevalence, which may limit generalizability and cannot establish causality.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 20 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Only 7% of men with type 1 diabetes had low total testosterone.”
- Also stated in: § Prevalence of testosterone deficiency in men with type 1 diabetes · plain
“Few men with type 1 diabetes had low TT (7.2%, P Ͻ 0.001, vs. type 2 diabetes, Fig. 1).”
- Also stated in: § Statistical analysis · plain
“Low TT (Ͻ10 nmol/liter) (%) 7% 43% 42%”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Abstract
Strength:plain· not yet calibratedn = 69Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Also stated in: § Prevalence of testosterone deficiency in men with type 1 diabetes · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“57% had a reduced calculated free testosterone”
- Also stated in: § Discussion · plain
“57% had low cFT levels”
- Also stated in: § Statistical analysis · plain
“Low cFT (Ͻ0.23 nmol/liter) (%) 20% 57% 60%”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § Discussion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After adjusting for age, body mass index (BMI), and other confounding factors, the frequency of low TT levels remained significantly higher in men with type 2 diabetes when compared with those with type 1 diabetes (adjusted odds ratio ϭ 4.0; 95% CI ϭ 1.5-10.7;P ϭ 0.005).”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Prevalence of testosterone deficiency in men with type 1 diabetes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For each decade of life, the prevalence of low cFT levels effectively doubled (adjusted odds ratio for low cFT levels ϭ 2.4; 95% CI ϭ 1.4 -3.9).”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Prevalence of testosterone deficiency in men with type 1 diabetes
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“This frequency of low TT levels in men with type 1 diabetes was not significantly greater than observed in reproductively normal young men (21).”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Prevalence of testosterone deficiency in men with type 1 diabetes
What the sources say
- Not checked yetcites [21] Sikaris, 2005, Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays., J Clin Endocrinol Metab source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As in men with type 2 diabetes, the major predictor of cFT levels in individuals with type 1 diabetes was age (Fig. 2B).”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Prevalence of testosterone deficiency in men with type 1 diabetes
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, when SHBG was included in the model, this difference between type 1 and type 2 diabetes was eliminated (P ϭ 0.16).”
- Also stated in: § Discussion · plain
“When SHBG was included into the model, this difference between type 1 and type 2 diabetes was eliminated (P ϭ 0.16).”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Prevalence of testosterone deficiency in men with type 1 diabetes
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § Discussion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“20.3% of men with type 1 diabetes had low calculated free testosterone”
- Also stated in: § Prevalence of testosterone deficiency in men with type 1 diabetes · plain
“one in five men with type 1 diabetes had low cFT levels (20.3%, Fig. 1)”
- Also stated in: § Statistical analysis · plain
“Low cFT (Ͻ0.23 nmol/liter) (%) 20% 57% 60%”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § Prevalence of testosterone deficiency in men with type 1 diabetes · plain
In the paper
“insulin resistance (as estimated by the HOMA-IR equation) (23) was independently associated with low TT levels (odds ratio ϭ 1.2; 95% CI ϭ 1.0 -1.4), after adjusting for age, BMI, treatment regimens, and other potentially confounding variables.”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Testosterone indices and insulin resistance
What the sources say
- Not checked yetcites [23] Wallace, 2004, Use and abuse of HOMA modeling., Diabetes Care source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The inverse association between cFT levels and age (Fig. 2B) was significantly stronger that that observed for TT (P Ͻ 0.01)”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Prevalence of testosterone deficiency in men with type 2 diabetes
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes
- It may state two separate claims as one. 6
- Probably not a substantial claim. 10
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“finding that 27 and 33% of individuals with low TT and cFT levels respectively had levels in the normal range when retested.”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Discussion
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“At the second analysis, the prevalence of testosterone deficiency defined by low TT levels (Ͻ10 nmol/liter) was not significantly different from obtained at the first estimation (39 vs. 42%, P ϭ 0.2), and there was a strong correlation between estimations (r 2 ϭ 0.73, Fig. 3A).”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Changes in testosterone levels over time
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“whereas the utility of testosterone replacement remains to be established in prospective trials.”
- Also stated in: § Discussion · hedged
“Although there is a strong rationale for testosterone replacement, the balance of benefits and risks is currently unknown and still to be defined by large and long-term clinical trials.”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Abstract
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Also stated in: § Discussion · hedged
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“possibly because of the age-associated rise in SHBG (Fig. 2C).”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Prevalence of testosterone deficiency in men with type 2 diabetes
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“None of these men received testosterone therapy.”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Changes in testosterone levels over time
Strength:plain· not yet calibratedn = 262Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Interpretation of our study is therefore limited because we did not obtain a detailed record of symptomatology history.”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“All men gave written informed consent, and the study was approved by the Human Research Ethics Committee, Research Ethics Unit, Austin Health.”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Cross-sectional survey
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“However, testosterone may have deleterious actions on prostate disease, sleep apnea, and possibly cardiovascular risk (35).”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Discussion
What the sources say
- Not checked yetcites [35] Rhoden, 2004, Risks of testosterone-replacement therapy and recommendations for monitoring., N Engl J Med source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Consequently, the appropriate clinical response to this emerging problem remains to be determined.”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Discussion
Strength:plain· not yet calibratedTests✓ Asserted: passes✗ Checkable: fails✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence. The paper’s conclusions may not depend on it.
In the paper
“previous studies have reported an association of loss of weight in obese insulinresistant men with increased testosterone levels (30).”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Discussion
What the sources say
- Not checked yetcites [30] Niskanen, 2004, Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome., Diabetes Obes Metab source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Certainly, testosterone replacement can improve performance, mood, and libido in men with hypogonadism (22) and augments insulin sensitivity (11,15).”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Discussion
What the sources say
- Not checked yetcites [22] Bhasin, 2006, Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline., J Clin Endocrinol Metab [Erratum (2006) 91:1995–2010] source
- Not checked yetcites [11] Kapoor, 2006, Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes., Eur J Endocrinol source
- Not checked yetcites [15] Simon, 2001, Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial., Diabetes Care source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The strengths of this study include the large number subjects, inclusion of a large cohort of patients with type 1 diabetes, measurement of serum testosterone levels at the appropriate time of day (early morning), accurate assays for total and free testosterone levels, and longitudinal follow-up in a substantial number of men with type 2 diabetes.”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Discussion
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“Indeed, reduced SHBG has been suggested as a surrogate marker for insulin resistance (33).”
§ Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes > Discussion
What the sources say
- Not checked yetcites [33] Jayagopal, 2003, The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance., J Clin Endocrinol Metab source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
The cohort of men attending a single tertiary referral clinic is representative of men with diabetes generally.
“in a large, unselected cohort of men with type 1 or type 2 diabetes presenting at a single center”
“large unselected cohort of men presenting to a single tertiary referral center”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In fact, multiple studies confirmed the association between low or inappropriate T levels in men and T2D and obesity [167–170].”
From Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology (2022) · cites this paper as [168]
In the citing paper
“A longitudinal study in 265 men with a baseline hemoglobin A1c of 7.6% reported an inverse relationship between changes in glycemic control and testosterone levels.”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [35]
In the citing paper
“In those whose glycemic control improved over time, testosterone increased, whereas in those whose control worsened, testosterone decreased (35).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [35]
In the citing paper
“Approximately, 50% of older (age >40 years) male patients with type 2 diabetes mellitus (DM2) have decreased testosterone (T) levels”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Overall hs-CRP median is below both reported subgroup medians
MajorThe reported hs-CRP medians for men with and without low TT are 7.7 and 4.5, respectively. The overall type 2 diabetes median in Table 1 is 3.0, which cannot be below both subgroup medians if these are the same cohort.
“higher hs-CRP levels (median 7.7 vs. 4.5, P Ͻ 0.01)”
“hs-CRP (IU/ml) 1.5 (0.2-11.5) 3.0 (0.2-192) 2.9 (0.2-58)”
Macrovascular disease prevalence differs from Table 1
MinorThe results describe macrovascular disease in one third of men with type 2 diabetes, but Table 1 reports 42% for that group.
“One third of men with type 2 diabetes had documented macrovascular disease”
“Macrovascular disease (%) 16% 42% 40%”
Citations
Cites
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Kapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791
Risks of testosterone-replacement therapy and recommendations for monitoring.
Rhoden, E. L., & Morgentaler, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra022251 · Cited by 705
Androgens and Cardiovascular Disease
Liu, P. Y., Death, A. K., & Handelsman, D. J. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0005 · Cited by 695
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
Can clinical factors estimate insulin resistance in type 1 diabetes?
Williams, K. V., Erbey, J. R., Becker, D., Arslanian, S., & Orchard, T. J. (2000) · Diabetes · doi:10.2337/diabetes.49.4.626 · Cited by 640
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 469
Hamilton, E. J., Davis, W. A., Makepeace, A., Lim, E. M., Yeap, B. B., Peters, K. E., & Davis, T. M. E. (2016) · Clinical Endocrinology · doi:10.1111/cen.13087 · Cited by 18
Clinical Implications of the Coexistence of Anemia and Diabetes Mellitus in the Elderly Population
Michalak, S. S., Wolny-Rokicka, E. I., Nowakowska, E., Michalak, M., & Gil, L. (2021) · Journal of Diabetes Research · doi:10.1155/2021/8745968 · Cited by 19
Cardiometabolic indices predict hypogonadism in male patients with type 2 diabetes
Caretta, N., Facondo, P., Mereu, S., Delbarba, A., Crepaldi, M., Vedovato, M., Avogaro, A., & Ferlin, A. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01941-0 · Cited by 18
Biswas, M., Hampton, D., Turkes, A., Newcombe, R. G., & Rees, A. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03824.x · Cited by 18
Liu, H., Chung, M., Wang, H., Liu, R., & Chuang, Y. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1310-3 · Cited by 18
Testosterone deficiency, metabolic syndrome and diabetes mellitus
Fernández-Miró, M., Chillarón, J. J., & Pedro‐Botet, J. (2016) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2015.06.002 · Cited by 18
Dayton, K. A., Bril, F., Barb, D., Lai, J., Kalavalapalli, S., & Cusi, K. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251449 · Cited by 17
Effects of androgens on glucose metabolism
Umapathysivam, M. M., Grossmann, M., & Wittert, G. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101654 · Cited by 18
Self-citationSepu, N., Adeleye, J. O., & Kuti, M. A. (2021) · Journal of the National Medical Association · doi:10.1016/j.jnma.2020.11.014 · Cited by 16
Testicular Dysfunction in Systemic Diseases
Sartorius, G. A., & Handelsman, D. J. (2010) · Springer eBooks · doi:10.1007/978-3-540-78355-8_18 · Cited by 16
Chillarón, J. J., Fernández-Miró, M., Albareda, M., Vila, L., Colom, C., Fontserè, S., Pedro‐Botet, J., on behalf of the TEST-DM1 Study Group, & Roux, J. A. F. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12748 · Cited by 15
Rabijewski, M., Papierska, L., Kuczerowski, R., & Piątkiewicz, P. (2015) · The Aging Male · doi:10.3109/13685538.2015.1083972 · Cited by 16
Pintana, H., Pongkan, W., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0099 · Cited by 16
Impact of Acute Biochemical Castration on Insulin Sensitivity in Healthy Adult Men
Rabiee, A., Dwyer, A. A., Caronia, L. M., Hayes, F. J., Yialamas, M. A., Andersen, D. K., Thomas, B. J., Torriani, M., & Elahi, D. (2010) · Endocrine Research · doi:10.3109/07435801003705601 · Cited by 17
Swerdlow, A. J., Jones, M. E., Slater, S. D., Burden, A. C., Botha, J. L., Waugh, N. R., Morris, A. D., Gatling, W., Gillespie, K. M., Patterson, C., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34548 · Cited by 15
The prevalence of Hypogonadism among diabetic and non-diabetic men in Jordan
Hayek, A. A., Khawaja, N. M., Khader, Y. S., Jafal, S., & Ajlouni, K. M. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.11.004 · Cited by 15
Correlates and prevalence of hypogonadism in patients with early‐ and late‐onset type 2 diabetes
Li, Y., Zhang, M., Liu, X., Cui, W., Rampersad, S., Li, F., Lin, Z., Yang, P., Li, H., Sheng, C., et al. (2017) · Andrology · doi:10.1111/andr.12360 · Cited by 15
Manigrasso, M. B., Sawyer, R. T., Hutchens, Z. M., Flynn, E. R., & Maric‐Bilkan, C. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00569.2011 · Cited by 15
Men's Health, Low Testosterone, and Diabetes Individualized
Rice, D., Brannigan, R. E., Campbell, R. K., Fine, S. R., Jack, L., Nelson, J. B., & Regan-Klich, J. (2008) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721708327143 · Cited by 14
Hu, S., Chen, S., Li, Z., Wang, Y., & Wang, Y. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.47555 · Cited by 15
Comparison of Testosterone Levels in Patients With and Without Type 2 Diabetes
Kumari, N., Khan, A., Shaikh, U. H., Lobes, K., Kumar, D., Suman, F., Bhutto, N. S., Anees, F., Shahid, S., & Rizwan, A. (2021) · Cureus · doi:10.7759/cureus.16288 · Cited by 14
Shevach, J. W., Gallagher, E. J., Kochukoshy, T., Gresia, V., Brar, M., Galsky, M. D., & Oh, W. K. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00129 · Cited by 14
Late-onset hypogonadism among old and middle-aged males with prediabetes in Polish population
Rabijewski, M., Papierska, L., & Piątkiewicz, P. (2015) · The Aging Male · doi:10.3109/13685538.2015.1004048 · Cited by 14
Turki, A., Mzoughi, S., Mtitaoui, N., Khairallah, M., Marmouch, H., Hammami, S. O., Mahjoub, T., & Almawi, W. Y. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0734-7 · Cited by 14
Guan, L., Hou, W. L., Zhu, Z. H., Cao, J., Tang, Z., Yin, X. Y., Xu, D. W., Yu, X., Jia, Q. F., Tang, W. J., et al. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.11.022 · Cited by 14
Mei, Y., Chen, Y., Wang, X., Xu, R., & Feng, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1458193 · Cited by 13
Zhu, H., Wang, N., Han, B., Qin, L., Chen, Y., Zhu, C., Chen, Y., Xia, F., Cang, Z., Lu, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162004 · Cited by 13
Shinlapawittayatorn, K., Pongkan, W., Sivasinprasasn, S., Chattipakorn, S. C., & Chattipakorn, N. (2022) · Nutrition and Diabetes · doi:10.1038/s41387-022-00189-0 · Cited by 12
Yang, U. S., Harikrishna, A., Preda, V. A., & Chen, J. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.09.001 · Cited by 12
Sex hormones in Malay and Chinese men in Malaysia: are there age and race differences?
Chin, K., Soelaiman, I. N., Mohamed, I. N., Ahmad, F., Ramli, E. S. M., Aminuddin, A., & Ngah, W. Z. W. (2013) · Clinics · doi:10.6061/clinics/2013(02)oa07 · Cited by 12
Allan, C. A., Peverill, R. E., Strauss, B. J., Forbes, E. A., & McLachlan, R. I. (2011) · Asian Journal of Andrology · doi:10.1038/aja.2011.13 · Cited by 11
de Oliveira, J. S., Silva, A. A. D. N., Dias, F. C. R., de Oliveira, E. L., Filho, E. F. D. O., Soares, P. C., Ferreira, C. M. D. O., & da Silva, V. A. (2022) · International Journal of Experimental Pathology · doi:10.1111/iep.12446 · Cited by 13
Diabetes and Cancer: Epidemiological, Clinical, and Experimental Perspectives
Tseng, C., Chen, C., & Landolph, J. R. (2012) · Experimental Diabetes Research · doi:10.1155/2012/101802 · Cited by 13
Assessment of hypogonadism and its determinants among adult men with type 2 diabetes mellitus
Singh, J., Sahoo, A., Swain, J., Mangaraj, S., Kanwar, J. B., & Manglunia, A. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.05.005 · Cited by 11
Functional state of the hypothalamic-pituitary-gonadal axis in diabetes mellitus
Shpakov, A. O. (2010) · Problems of Endocrinology · doi:10.14341/probl201056523-29 · Cited by 11
Angiotensin blockade attenuates diabetic nephropathy in hypogonadal adult male rats
Makary, S., Abdo, M., Hassan, W. A., & Tawfik, M. K. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0572 · Cited by 10
Wh, K., Sithik, M. N. B. M., Khoo, J. K., Ooi, Y., Lim, Q., & Lim, L. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13903 · Cited by 11
Association between anemia and serum Klotho in middle-aged and older adults
An, C., Chen, X., & Zheng, D. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03081-w · Cited by 11
Rabijewski, M., Papierska, L., & Piątkiewicz, P. (2017) · The Aging Male · doi:10.1080/13685538.2017.1338254 · Cited by 12
Wu, Y., Yang, C., Meng, F., Que, F., Xiao, W.-X., Rao, H., Wan, Y., Taylor, H. S., & Lu, L. (2018) · Reproductive Sciences · doi:10.1177/1933719118773421 · Cited by 11
Kim, D. K., Noh, J., Chang, Y., Lee, H. Y., Park, J. J., Ryu, S., & Kim, J. H. (2020) · Andrology · doi:10.1111/andr.12806 · Cited by 11
Prostate Carcinogenesis with Diabetes and Androgen-Deprivation-Therapy-Related Diabetes: An Update
Hara, N. (2012) · Experimental Diabetes Research · doi:10.1155/2012/801610 · Cited by 11
Minooee, S., Tehrani, F. R., Rahmati, M., Soudmand, S. A., Tohidi, M., Sabet, Z., & Azizi, F. (2019) · Andrology · doi:10.1111/andr.12568 · Cited by 11
Testosterone and Glucose Homeostasis in Adult Males: Current Insights and Future Prospects
Milionis, C., Koukkou, E. G., Venaki, E., & Ilias, Ι. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436184.81 · Cited by 12
Zhang, B., Gu, Y., Chen, Y., Xia, W., Shao, N., Zhuang, Q., & Feng, X. (2025) · Sexual Medicine · doi:10.1093/sexmed/qfaf012 · Cited by 10
Pasquali, D., Chiodini, P., Simeon, V., Ferlin, A., Vignozzi, L., Corona, G., Lanfranco, F., Rochira, V., Calogero, A. E., Bonomi, M., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01816-4 · Cited by 11
Jiang, C., Wang, Y., Yang, W., & Yang, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1238090 · Cited by 10
Cai, M., Cui, R., Yang, P., Gao, J., Cheng, X., Sheng, C., Li, H., Sheng, H., Qu, S., & Zhang, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.675525 · Cited by 11
Venkataraman, B., Williams, A. A., Sathish, S., Mayilvanan, C., Narasimhan, A., & Balasubramanian, K. (2012) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587212451027 · Cited by 10
Veissi, M., Jafarirad, S., Ahangarpour, A., Mohaghegh, S. M., & Malehi, A. S. (2018) · Endocrine Regulations · doi:10.2478/enr-2018-0009 · Cited by 10
Diabetes surpasses obesity as a risk factor for low serum testosterone level
Khalil, S. H. A., Dandona, P., Osman, N. A., Assaad, R. S., Zaitoon, B. T. A., Almas, A. A., & Amin, N. G. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01373-1 · Cited by 11
Hormazábal‐Aguayo, I., Huerta‐Uribe, N., Muñoz‐Pardeza, J., Ezzatvar, Y., Izquierdo, M., & García‐Hermoso, A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae451 · Cited by 10
Hypergonadotropic hypogonadism in Nigerian men with type 2 diabetes mellitus
Musa, E., El-Bashir, J. M., Bello-Sani, F., & Bakari, A. G. (2021) · Clinical Diabetology · doi:10.5603/dk.a2021.0002 · Cited by 9
Testosterone Deficiency Associated with Poor Glycemic Control in Korean Male Diabetics
Kim, J., Kim, B. S., Jeon, J. Y., Choi, Y. J., & Chung, Y. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.3.300 · Cited by 9
Karışmaz, A., Soysal, P., Eren, R., Serin, İ., Aslan, C., Rahmati, M., Yon, D. K., & Smith, L. (2024) · Aging Clinical and Experimental Research · doi:10.1007/s40520-024-02859-8 · Cited by 8
Chin, K., Soelaiman, I. N., Mohamed, I. N., Johari, M. H., & Ngah, W. Z. W. (2012) · Intern J Endocrinol Metab · doi:10.5812/ijem.3937 · Cited by 8
Hua, Q., Zhu, Y., Liu, H., & Ye, X. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1316-x · Cited by 8
Chodari, L. (2017) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2017.266 · Cited by 8
The implications of hyperoxia, type 1 diabetes and sex on cardiovascular physiology in mice
Bojkovic, K., Rodgers, J. L., Vichare, R., Nandi, A., Mansour, N., Saleem, F., Abıdın, Z. U., Vanthenapalli, S., Cheng, F., & Panguluri, S. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-02550-2 · Cited by 8
Steroid profiling and genetic variants in Chinese women with gestational diabetes mellitus
Yuan, T., & Li, Y. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105999 · Cited by 8
Mirzaei, M. R., Amini, M., & Aminorroaya, A. (2012) · Europe PMC (PubMed Central) · Cited by 8
Low Serum Testosterone Concentrations in Hospitalized Men with Poorly Controlled Type 2 Diabetes
Kim, K., Kang, S.-H., Kim, M.-J., Kim, S.-K., Kim, Y.-L., Park, W.-K., Park, S. W., & Cho, Y.-W. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.4.574 · Cited by 8
Effects of varying doses of testosterone on atherogenic markers in healthy younger and older men
Roberts, C. K., Chen, B. H., Pruthi, S., & Lee, M. L. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00372.2013 · Cited by 8
A case of Madelung's disease accompanied by Klinefelter's syndrome
Özderya, A., Temizkan, Ş., Tezcan, K. A., Öztürk, F. Y., & Altuntaş, Y. (2015) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-14-0119 · Cited by 8
Windows of opportunity: a holistic approach to men's health*
Holden, C. A., Allan, C. A., & McLachlan, R. I. (2010) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2010.tb03708.x · Cited by 8
Zajac, J. D., & Fui, M. N. T. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5434-2_10 · Cited by 8
Self-citationCharlier, C. M., Barr, M. L., Colby, S. E., Greene, G. W., & Olfert, M. D. (2018) · Healthcare · doi:10.3390/healthcare6040121 · Cited by 8
Serum testosterone levels in type 2 diabetes mellitus
Kundu, D., Ghosh, E., Roy, S., & Basu, S. (2018) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2018.i08.03 · Cited by 8
The mediation role of SOCS3 methylation in the effect of serum testosterone on type 2 diabetes
Wang, L., Liu, X., Wei, D., Kang, N., Nie, L., Liu, P., Fan, K., Zhang, L., Hou, J., Li, X., et al. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13167 · Cited by 8
Reproductive Dysfunctions in Males with Type 2 Diabetes Mellitus: An Updated Review
Ray, S., & Pramanik, S. (2020) · EMJ Diabetes · doi:10.33590/emjdiabet/20-00171 · Cited by 8
The Association of Free Testosterone Levels in Men and Lifestyle Factors and Chronic Disease Status
Cardarelli, R., Singh, M., Meyer, J., Balyakina, E., Perez, O., & King, M. R. (2014) · Journal of Primary Care & Community Health · doi:10.1177/2150131913520234 · Cited by 7
Total Testosterone Levels and the Effect of Sildenafil on Type 2 Diabetics with Erectile Dysfunction
Fadhil, N. N., Thanoon, I. A.-J., & Al-Mukhtar, S. B. (2014) · Oman Medical Journal · doi:10.5001/omj.2014.10 · Cited by 7
Hypogonadismus und infertilität bei systemischen Erkrankungen
Sartorius, G. A., & Handelsman, D. J. (2009) · Springer eBooks · doi:10.1007/978-3-540-92963-5_18 · Cited by 7
Can Serum Testosterone Be Used as a Marker of Overall Health?
Mederos, M. A., Bernie, A., Scovell, J. M., & Ramasamy, R. (2015) · PubMed Central · Cited by 7
Effect of Testosterone on Memory and BDNF Levels of Hippocampus in Gonadectomized Diabetic Rats
Ebrahimzadeh, M., Shahabi, P., Mohaddes, G., Babri, S., Mohammadi, M., Moslem, A., & Mohammad‐Zadeh, M. (2015) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/1921 · Cited by 7
Hypogonadism in Systemic Diseases
Rochira, V. (2017) · Endocrinology · doi:10.1007/978-3-319-29456-8_28-1 · Cited by 7
Shaheen, D. (2014) · Advances in Biochemistry · doi:10.11648/j.ab.20140202.12 · Cited by 7
Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism)
Saad, F. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_23 · Cited by 6
Long-term follow-up of gonadal dysfunction in morbidly obese adolescent boys after bariatric surgery
Chin, V. L., Willliams, K. M., Donnelley, T., Censani, M., Conroy, R., Lerner, S. E., Oberfield, S. E., McMahon, D. J., Zitsman, J. L., & Fennoy, I. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0261 · Cited by 7
Obesity and Testicular Function
Ilacqua, A., Francomano, D., & Aversa, A. (2014) · Springer eBooks · doi:10.1007/978-3-319-09045-0_10 · Cited by 7
Sex hormones, obesity and type 2 diabetes-is there a link?
Gambineri, A. (2018) · Endocrine Abstracts · doi:10.1530/endoabs.56.s18.1 · Cited by 7
Zheng, R., Daniels, J. P., Moreira, D. M., Eslamimehr, S., Freedland, A. R., Guerrios‐Rivera, L., Fowke, J. H., & Freedland, S. J. (2024) · Cancer · doi:10.1002/cncr.35568 · Cited by 6
Comparative effects of sex hormone deprivation on the brain of insulin-resistant rats
Sripetchwandee, J., Pintana, H., Sa‐nguanmoo, P., Boonnag, C., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0552 · Cited by 6
Majumdar, S., Mukherjee, J. J., Ray, S., Goswami, S., Jude, E. B., Biswas, A. K., Hanumanthu, A., John, M., Sinha, B., Ghosal, S., et al. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102191 · Cited by 8
Al-Bashiti, A., Ahmed, K. A., & Alqaisi, K. M. (2022) · Journal of Medical Biochemistry · doi:10.5937/jomb0-35601 · Cited by 6
Almuraikhy, S., Anwardeen, N. R., Naeem, A., Sellami, M., Dömling, A. S. S., Agouni, A., & Elrayess, M. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912169 · Cited by 6
Nutritional Treatment of Diabetic Foot Ulcers - A Key to Success
Tatti, P., & Barber, A. E. (2011) · InTech eBooks · doi:10.5772/27418 · Cited by 6
Kumar, R., Malhotra, N., & Jacob, J. J. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.01.009 · Cited by 6
Park, M. S., Kim, S., & Won, Y.-I. (2020) · Journal of Men s Health · doi:10.31083/jomh.v16i4.328 · Cited by 6
Testosterone levels increase in association with recovery from acute fracture in men
Cheung, A. S., Baqar, S., Sia, R., Hoermann, R., Iuliano-Burns, S., Vu, T. D. T., Chiang, C. Y., Hamilton, E. J., Gianatti, E., Seeman, E., et al. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2727-0 · Cited by 6
Self-citationBarkabi-Zanjani, S., Chodari, L., Bavil, F. M., Sadeghzadeh, P., & Shahabi, P. (2019) · Physiology International · doi:10.1556/2060.106.2019.08 · Cited by 6
Hypogonadism among Jordanian men with type 2 diabetes: Prevalence and associated factor
Hayek, A. A., Khader, Y. S., Jafal, S., Khawaja, N. M., & Ajlouni, K. M. (2011) · International Journal of Diabetes Mellitus · doi:10.1016/j.ijdm.2011.01.003 · Cited by 6
Jackuliak, P., Jankovský, M., Kovářová, M., Voller, J., Feitscherova, C., & Varga, I. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1582039 · Cited by 5
Silva, N. D., Quinton, R., de Silva, N. L., Jayasena, C. N., Barbar, B., Boot, C., Wright, R. J., Shipley, T. W., & Kanagasundaram, N. S. (2024) · Clinical Endocrinology · doi:10.1111/cen.15146 · Cited by 5
Wu, F. C. W. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101626 · Cited by 6
Huang, R., Wang, Y., Yan, R., Ding, B., & Ma, J. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01445-x · Cited by 5
Selvam, M. K. P., Baskaran, S., Tannenbaum, J., Greenberg, J. W., Shalaby, H., Hellstrom, W. J. G., & Sikka, S. C. (2023) · Medicina · doi:10.3390/medicina59111902 · Cited by 5
Complications de l’hormonothérapie anti-androgénique du cancer de la prostate
Ziouziou, I., Karmouni, T., Khader, K. E., Koutani, A., & andaloussi, A. I. A. (2014) · Canadian Urological Association Journal · doi:10.5489/cuaj.1608 · Cited by 6
Bajaj, S., Srivastava, A., Varma, A., & Tiwari, A. (2016) · Sri Lanka Journal of Diabetes Endocrinology and Metabolism · doi:10.4038/sjdem.v6i1.7300 · Cited by 5
Association between T2DM and the lowering of testosterone levels among Kashmiri males
Farooq, R., Bhat, M. H., Majid, S., & Mir, R. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000288 · Cited by 6
Metadata
- Authors
- Grossmann, M., Thomas, M. C., Panagiotopoulos, S., Sharpe, K., MacIsaac, R. J., Clarke, S., Zajac, J. D., & Jerums, G.
- Affiliations
- The University of Melbourne (AU)
- Baker Heart and Diabetes Institute (AU)
- Corresponding author
- Grossmann, Mathis
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-05-01
- Volume
- 93
- Issue
- 5
- Pages
- 1834-1840
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1975633687
- Semantic Scholar
- 02f5d7f00e960755b4687b5424387d4da02771b3
- Cited by
- 468
- References
- 37
- Citations by year
- 2026: 22 · 2025: 22 · 2024: 22 · 2023: 23 · 2022: 28 · 2021: 24 · 2020: 23 · 2019: 15 · 2018: 24 · 2017: 33 · 2016: 34 · 2015: 30 · 2014: 41 · 2013: 31 · 2012: 30
- FWCI
- 15.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- androgen deficiency, insulin resistance, type 2 diabetes, type 1 diabetes, men, free testosterone, total testosterone, testosterone replacement therapy, prevalence
- MeSH terms
- Adult, Aged, Cross-Sectional Studies, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Male, Middle Aged, Sex Hormone-Binding Globulin, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
